Skip to main content

Advertisement

Log in

Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 22 August 2012

Abstract

Background

Hypoxia is a common feature of rapidly growing solid tumors. Therefore, cellular adaptation to hypoxia and altered glucose metabolism are fundamental to the biology of cancer cells. Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor for more than 60 genes recognized to control the delivery of oxygen and nutrients through the induction of angiogenesis and glycolysis under hypoxic conditions. Therefore, inhibition of the expression of HIF-1α can be expected to be potentially tumor-specific molecular target-based therapy. In this study, we evaluated the significance of HIF-1α expression in relationship to clinicopathological factors, prognosis, vascular endothelial growth factor (VEGF) expression, and microvessel density (MVD).

Methods

Paraffin-embedded tumor specimens from 128 patients who underwent gastrectomy at Kurume University from 2004 to 2005 were used to assess the clinical significance of HIF-1α expression. We used the ABC method to perform an immunohistochemical analysis of the HIF-1α and VEGF expression.

Results

Eighty-four (65.6%) of gastric cancer specimens were positive for HIF-1α expression. Multivariate analysis showed that histology, depth of invasion, VEGF expression, and MVD were significantly associated with HIF-1α expression. On relapse-free and overall survival curves, the HIF-1α-negative group was significantly higher than the HIF-1α-positive group. Moreover, HIF-1α(+)/VEGF(+) patients had the worst prognosis. HIF-1α expression was identified as a significant predictor of relapse-free survival and overall survival by multivariate Cox’s proportional hazard analyses.

Conclusion

Overexpression of HIF-1α was found to be an indicator of poor prognosis for patients with gastric cancer and was significantly correlated with histology, depth of invasion, VEGF, and MVD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543

    Article  PubMed  CAS  Google Scholar 

  2. Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26:281–290

    Article  PubMed  CAS  Google Scholar 

  3. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186

    Article  PubMed  CAS  Google Scholar 

  4. Gatenby RA, Kessler HB, Rosenblum JS et al (1988) Oxygen distribution in squamous cell carcinoma metastasis and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14:531–538

    Article  Google Scholar 

  5. Takahashi R, Tanaka S, Hiyama T et al (2003) Hypoxia-inducible factor 1 alpha expression and angiogenesis in gastrointestinal stromal tumor of stomach. Oncol Rep 10:797–802

    PubMed  CAS  Google Scholar 

  6. Zhong H, Agani F, Baccala AA et al (1998) Increased expression of hypoxia-inducible factor 1 alpha in rat and human prostate cancer. Cancer Res 58:5280–5284

    PubMed  CAS  Google Scholar 

  7. Chen WT, Huang CJ, Wu MT et al (2005) Hypoxia-inducible factor 1 alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol 35:207–213

    Article  PubMed  Google Scholar 

  8. Mizokami K, Kakeji Y, Oda S et al (2006) Clinicopathological significance of hypoxia-inducible factor 1 alpha overexpression in gastric carcinomas. J Surg Oncol 94:149–154

    Article  PubMed  CAS  Google Scholar 

  9. Yoshikawa T, Tsuburaya A, Miyagi Y et al (2006) Up-regulation of hypoxia-inducible factor 1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer. Anticancer Res 63:3849–3854

    Google Scholar 

  10. Sumiyoshi Y, Kakeji Y, Egashira A et al (2006) Overexpression of hypoxia-inducible factor 1 alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 12:5112–5117

    Article  PubMed  CAS  Google Scholar 

  11. Stoeltzing O, McCarty MF, Wey JS et al (2004) Role of hypoxia-inducible factor 1 alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 96:946–956

    Article  PubMed  CAS  Google Scholar 

  12. Fukuda R, Kelly B, Semenza GL (2003) Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 63:2330–2334

    PubMed  CAS  Google Scholar 

  13. Koshikawa N, Iyozumi A, Gassmann M (2003) Constitutive upregulation of hypoxia-inducible factor 1 alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. Oncogene 22:6717–6724

    Article  PubMed  CAS  Google Scholar 

  14. Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345–350

    Article  PubMed  CAS  Google Scholar 

  15. Saramaki OR, Savinainen KJ, Nupponen NN et al (2001) Amplification of hypoxia-inducible factor 1 alpha gene in prostate cancer. Cancer Genet Cytogenet 128:31–34

    Article  PubMed  CAS  Google Scholar 

  16. Ravi R, Mookerjee B, Bhujwalla ZM et al (2000) Regulation of tumor angiogenesis by p53 induced degradation of hypoxia-inducible factor 1α. Genes Dev 14:34–44

    PubMed  CAS  Google Scholar 

  17. Kung AL, Wang S, Klco JM et al (2000) Suppression of tumor growth through disruption of hypoxia inducible transcription. Nat Med 6:1335–1340

    Article  PubMed  CAS  Google Scholar 

  18. Akakura N, Kobayashi M, Horiuchi I et al (2001) Constitutive expression of hypoxia-inducible factor-1 alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 61:6548–6554

    PubMed  CAS  Google Scholar 

  19. Dalgard CL, Lu H, Mohyedin A et al (2004) Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J 380:419–424

    Article  PubMed  CAS  Google Scholar 

  20. Huang LE, Gu J, Schau M (1998) Regulation of hypoxia-inducible factor 1 alpha is mediated by O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987–7992

    Article  PubMed  CAS  Google Scholar 

  21. Talks KL, Turley H, Gatter KC et al (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157:411–421

    Article  PubMed  CAS  Google Scholar 

  22. Chun YS, Kim MS, Park JW (2002) Oxygen-dependent and -independent regulation of HIF-1alpha. J Korean Med Sci 17:581–588

    PubMed  CAS  Google Scholar 

  23. Shi YH, Fang WG (2004) Hypoxia-inducible factor-1 in tumor angiogenesis. World J Gastroenterol 10:1082–1087

    PubMed  CAS  Google Scholar 

  24. Stroka DM, Burkhardt T, Desbaillets I et al (2001) HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445–2453

    PubMed  CAS  Google Scholar 

  25. Zagzag D, Zhong H, Scalzitti JM et al (2000) Expression of hypoxia-inducible factor 1 alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer (Phila) 88:2606–2618

    Article  CAS  Google Scholar 

  26. Theodoropoulos VE, Lazaris A, Sofras F et al (2004) Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46:200–208

    Article  PubMed  CAS  Google Scholar 

  27. Bos R, Zhong H, Hanrahan CF et al (2001) Levels of hypoxia-inducible factor 1 alpha during breast carcinogenesis. J Natl Cancer Inst 93:309–314

    Article  PubMed  CAS  Google Scholar 

  28. Kuwa T, Kitada Y, Tanaka S et al (2003) Expression of hypoxia-inducible factor 1 alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105:176–181

    Article  Google Scholar 

  29. Wiesener MS, Munchenhagen PM, Berger I et al (2001) Constitutive activation of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas. Cancer Res 61:5215–5222

    PubMed  CAS  Google Scholar 

  30. Birner P, Schindl M, Obermair A et al (2001) Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 7:1661–1668

    PubMed  CAS  Google Scholar 

  31. Buchler P, Reber HA, Buchler M et al (2003) Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 26:56–64

    Article  PubMed  CAS  Google Scholar 

  32. Japanese Gastric Cancer Association (2010) Japanese classification of gastric carcinoma, 14th edn. Kanehara, Tokyo

    Google Scholar 

  33. Livingston DM, Shivdasani R (2001) Toward mechanism-based cancer care. JAMA 285:588–593

    Article  PubMed  CAS  Google Scholar 

  34. Oskoski R Jr (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62:179–213

    Article  Google Scholar 

  35. Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985

    Article  PubMed  CAS  Google Scholar 

  36. Dvorak HF, Brown LF, Detmar M et al (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039

    PubMed  CAS  Google Scholar 

  37. Nagy JA, Masse EM, Herzberg KT et al (1995) Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55:360–368

    PubMed  CAS  Google Scholar 

  38. Boocock CA, Charnock-Jones DS, Sharkey AM et al (1995) Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506–516

    Article  PubMed  CAS  Google Scholar 

  39. Aoyagi K, Kouhuji K, Takeda J et al (2005) VEGF significance in peritoneal recurrence from gastric cancer. Gastric Cancer 8:155–163

    Article  PubMed  CAS  Google Scholar 

  40. Imaizumi T, Aoyagi K, Shirouzu K et al (2010) Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model. Surg Today 40:851–857

    Article  PubMed  CAS  Google Scholar 

  41. Chen C, Pore N, Behrooz A et al (2001) Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276:9519–9525

    Article  PubMed  CAS  Google Scholar 

  42. Jiang BH, Agani F, Passaniti A et al (1997) V-SRC induces expression of hypoxia-inducible factor 1(HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57:5328–5335

    PubMed  CAS  Google Scholar 

  43. Laughner E, Taghavi P, Chiles K et al (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995–4004

    Article  PubMed  CAS  Google Scholar 

  44. Mazure NM, Chen EY, Laderoute KR et al (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90:3322–3331

    PubMed  CAS  Google Scholar 

  45. Aebersold DM, Burri P, Beer KT et al (2001) Expression of hypoxia-inducible factor 1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61:2911–2916

    PubMed  CAS  Google Scholar 

  46. Matuyama T, Nakanishi K, Hayashi T et al (2005) Expression of hypoxia-inducible factor 1α in esophageal squamous cell carcinoma. Cancer Sci 96:176–182

    Article  Google Scholar 

  47. Koukourakis MI, Giatromanolaki A, Skarlatos J et al (2001) Hypoxia-inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 61:1830–1832

    PubMed  CAS  Google Scholar 

  48. Beasley NJP, Leek R, Alam M et al (2002) Hypoxia-inducible factor HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62:2493–2497

    PubMed  CAS  Google Scholar 

  49. Griffiths EA, Pritchard SA, Valentine HR et al (2007) Hypoxia-inducible factor 1 alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastroesophageal adenocarcinomas. Br J Cancer 96:95–103

    Article  PubMed  CAS  Google Scholar 

  50. Krishnamachary B, Berg-Dixon S, Kelly B et al (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63:1138–1143

    PubMed  CAS  Google Scholar 

  51. Yuri K, Qun L, Daniel Z et al (2009) Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res 69:9271–9280

    Article  Google Scholar 

  52. Wen WM, Alex AA (2009) Novel agents on the horizon for cancer therapy. CA Cancer 59:111–137

    Article  Google Scholar 

Download references

Conflict of interest

No author has any conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keishiro Aoyagi.

About this article

Cite this article

Isobe, T., Aoyagi, K., Koufuji, K. et al. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer. Int J Clin Oncol 18, 293–304 (2013). https://doi.org/10.1007/s10147-012-0378-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-012-0378-8

Keywords

Navigation